Última Hora: "Lisboa vai proibir copos de plástico a partir de 2020 - Diário de Notícias - Lisboa" Wed, 18 Jul 2018 06:00:14 GMT    "Google vai recorrer da multa aplicada por Bruxelas - SIC Notícias" Wed, 18 Jul 2018 15:22:45 GMT    "Ryanair prevê cancelamento de 600 voos na Europa, 100 só em Portugal, devido à greve dos tripulantes - Observador" Wed, 18 Jul 2018 23:05:25 GMT    "Eurostat confirma inflação de 2% em Junho na Zona Euro - Jornal de Negócios - Portugal" Wed, 18 Jul 2018 09:21:29 GMT    "A "casa mais cara do mundo" foi vendida a metade do preço - Correio da Manhã" Wed, 18 Jul 2018 16:05:22 GMT    "Cláudia Azevedo, a filha com ?mais killer instinct? de Belmiro, vai ser a nova CEO da Sonae - Observador" Tue, 17 Jul 2018 19:55:17 GMT   "" Thu, 19 Jul 2018 02:33:59 GMT    "Mais de 62 mil pessoas investiram em obrigações do Estado português - Observador" Wed, 18 Jul 2018 18:08:32 GMT    "Açúcar dos pacotinhos nas grandes superfícies reduzido para metade - PÚBLICO" Wed, 18 Jul 2018 19:38:38 GMT    "Código do Trabalho: os oito diplomas que passaram o primeiro teste - Jornal de Negócios - Portugal" Wed, 18 Jul 2018 20:46:14 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Sem variação
Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última Trade0,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade - 00:00:00Price-Target 1 Ano0,000
VariaçãoN/A (N/A)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura0,000PER0,00%
Máximo0,000Pagamento Dividendo
Mínimo0,000Data Ex-Dividendo
Fecho Anterior0,000Yield
Volume0Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Desloratadine Market Report 2018 Global: Top Manufacturers Revenue, Type And Applications Prediction To 2025
theaerospacenews.com
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...
United States Desloratadine Market Growth Forecast Analysis by Manufacturers, Regions, Type and Application to 2025Newszak (blog)

todos os 4 artigos de notícias »

Allergy Treatment Market Rugged Expansion Foreseen by 2026
Digital Journal
... market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and ...

e mais »

LANews By Abhishek Budholiya (press release) (blog)

Allergy Treatment Market is Expecting Worldwide Growth by 2026
LANews By Abhishek Budholiya (press release) (blog)
... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.

e mais »

Desloratadine Market Research Report Includes Market Dynamics 2018: Opportunities, Risk And Driving Force ...
Stock Analysis
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Global Desloratadine Market 2018 Research Report Analysis By Emerging Trends, Growth Drivers, Outlook And ...
managementjournal24.com
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Positive Newspaper

Global Desloratadine Market Demand 2018- Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan ...
Positive Newspaper
Some of the well-known players in the market are Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing ...

e mais »

Desloratadine Market Drivers, Research Findings, Analyst Introduction, Data Source, Methodology till 2023
Healthcare Sector
Some of the key companies in the Global Desloratadine market include: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, ...

e mais »

Worldwide Desloratadine Market Report Global: Top Manufacturers Revenue, Type And Applications Estimate To 2023
theautomarketnews.com
Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan ...


BrainStorm Strengthens Executive Management Team with the Appointment of Susan Ward, Ph.D. and Joseph ...
PR Newswire (press release)
NEW YORK and PETACH TIKVAH, Israel, June 28, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the appointment of Joseph ... Dr ...

e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
GlobeNewswire (press release)
Mr. Hastings also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule's transition into a drug discovery and development organization, and in two ...


Global Desloratadine Market Company Basic Information, Manufacturing Base, Sales Area and Its Competitors with ...
The Newsman
Pfizer Teva Wante Pharmaceutical Novartis India Limited Mylan Sepracor Sandoz Apollo Pharmaceuticals GSK Mayne Pharma Inc Abhilasha Pharma Pvt Abbott Takeda Schering-Plough Nanjing Hicin Pharmaceutical Hairui Pharmaceutical Hainan Poly ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ...

e mais »

Business Wire (press release)

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma.

e mais »

Business Wire (press release)

Entasis Therapeutics Appoints David C. Hastings to Board of Directors
Business Wire (press release)
BUSINESS WIRE)--Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the appointment of David C. Hastings to the company's Board of ...

Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters